• English
  • Deutsch

You are here

Iccy 810

The Highlights of minimal invasive Laser Therapy.

Iccy 810 - Releasing pressure in the most easiest way.

Transscleral diode laser cyclophotocoagulation (CPC) has been established as long-term, effective intraocular pressure (IOP) lowering procedure for many types of glaucoma patients. It has become a popular alternative to surgical practices for refractory glaucoma. The surgery can be done before and after any other surgery, such as metabolite augmented trabeculectomy or viscocanalostomy. This makes it a very versatile procedure from which patients with refractory glaucoma and those with good visual acuity can benefit from.

Transscleral cyclophotocoagulation

The wavelength of 810 nm allows a safer treatment compared to other methods of cyclophotocoagulation or cyclocryotherapy, reducing the risk of hypotony and

phthisis. Using a specially designed probe, the laser beam passes the sclera and is absorbed by the ciliary body, which in turn results in coagulation. The sclera is not affected. The destruction of the ciliary body leads to significant reduction of the IOP. The treatment requires only local anesthetics and will be performed as an outpatient procedure.

Iccy 810: Technical Data

Model:
Iccy 810
Wavelength:
810+/- 5nm
Operation Modes:
CW, pulsed, Low-Level
Power:
0.5 – 7.0W, 10 – 100mW Low-Level
Pulse Width:
1ms – 1000ms
Interval:
1ms – 1000ms
Laser Class:
4
Pilot Beam:
635nm, < 1mW
Fiber:
200µm – 1000µm, F-SMA 905
Mains
230V~/ 50-60Hz
Consumption:
65W
Languages
English, German, French, Italian, Spanish, Portuguese, Czech,
Russian, Arabic, Farsi, Hebrew
DE

Made in Germany

qualität_box

Iccy 810_3
Iccy 980_1
Iccy 980_2